tumor microenvironment
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
tumor microenvironment
Apr 19, 2024, 05:17 |
Insight
Dina Schneider: Excited about our recent publication on Armored TGFBRIIdn ROR1-targeting CAR T cells for solid tumors
Dina Schneider, Director of Immuno Oncology and Cell Therapy at Lentigen Technology, shared on LinkedIn:…
Apr 11, 2024, 15:57 |
Insight
Marco Donia: Therapeutic Cancer Vaccines - update in Melanoma
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 8, 2024, 22:24 |
Insight
NSCLC's Immune Landscape: A Comprehensive Study of the Tumor Microenvironment
A recent study, “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical…
Apr 8, 2024, 15:24 |
Insight
Amalya Sargsyan: Fantastic paper out in AACR Journals on the role of TME in NSCLC
Amalya Sargsyan, Medical Oncologist at Yeolyan Oncology and Hematology Center, shared on LinkedIn: "Is targeting…
Mar 8, 2024, 14:46 |
Blog
María Natalia Gandur Quiroga: Unveiling New Players in the Tumor Microenvironment: Tumor-Resident Microbes
María Natalia Gandur Quiroga shared a post on LinkedIn: “Unveiling New Players in the Tumor Microenvironment:…
Feb 9, 2024, 17:42 |
Insight
Rafeh Naqash: Happy to share these two papers out today in the same issue of JCOPO_ASCO
Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Centre, shared an X post by…
Nov 22, 2023, 16:06 |
Blog
Shipra Gandhi: How a novel strategy can modulate the chemokine milieu in the TME
Shipra Gandhi, Translational Researcher at Roswell Park Comprehensive Cancer Center, shared a post by Journal…
Oct 14, 2023, 16:32 |
Insight
Daniel Chen: After a decade of immense progress for patients with cancer immunotherapy we are excited to publish a 10-year update, reflecting the complexity in the TME.
Daniel Chen, Founder of Engenuity Life Sciences, shared on LinkedIn: "We wrote the Cancer Immunity Cycle…
All:
8
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube